Abstract
We evaluated whether trough cyclosporine (CYA) level monitoring was useful in the diagnosis of rejection within 2 weeks after transplantation. Rejection occurred in 14 out of 17 patients (82.3%) treated with CYA, mizoribine (MZR) and prednisolone (Pred) when trough CYA levels dropped below 70 ng/ml, suggesting the importance of trough level monitoring. When anti-lymphocyte globulin (ALG) was added to the 3 above-mentioned drugs, however, rejection occurred in only 1 patient (6.7%) and 2 patients (13.3%), respectively, within 1 week and 1–2 weeks after transplantation, suggesting that through level monitoring isless important in patients treated with these 4 drugs.
Similar content being viewed by others
References
Calne, R. Y., White, D. J. G., Thiru, S.: Cyclosporine A in patients receiving renal allografts from cadaver donors.Lancet, 2, 1323 (1978).
Gravel J., Napoli, K. L., Gibbons, S.: Area under the curve monitoring of cyclosporine therapy: Performance of different, assay methods and their target concentration.Ther. Drug Monit., 12, 8 (1991).
Japanese FK506 study group. Japanese study of FK506 on kidney transplantation: The benefit of monitoring the whole blood FK506 concentration, an early phase II study.Transplant. Proc., 23, 3085 (1991).
Takahara, S., Fukunishi, T., Kokado, Y., Ichikawa, Y., Ishibashi, M., Nagano, S., Sonoda, T.: Combined immunosuppression with low dose cyclosporine, mizoribine and prednisolone.Transplant. Proc., 20, 147 (1988).
Kodako, Y., Ishibashi, M., Jiang, H., Takahara, S., Sonoda, T.: A new triple-drug therapy.Clin. Transplant., 4, 191 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takahara, S., Namiki, M., Kokado, Y. et al. Clinical assessment of trough levels for monitoring of rejection in cyclosporine-treated kidney transplant recipients. International Urology and Nephrology 28, 431–438 (1996). https://doi.org/10.1007/BF02550507
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02550507